Scinai Immunotherapeutics Ltd. (SCNI) Balance Sheet
As of 2025-12-31 (20-F), Scinai Immunotherapeutics Ltd. (SCNI) reported total assets of $11.6M and shareholders' equity of $8.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $1.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SCNIScinai Immunotherapeutics Ltd.Follow SCNI — free
—
Price chart with a free account
- Market cap
- 3.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- —
| Line | FY2017 Dec 17 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Dec 25 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 3.1 | 17.5 | 14.2 | 5.0 | 2.1 | 1.8 | 1.8 | |
| Receivables | — | — | — | — | — | 0.1 | 0.1 | 0.1 | |
| Current assets | 21.7 | 3.3 | 17.8 | 14.4 | 5.4 | 2.4 | 2.1 | 2.1 | |
| Total assets | 23.6 | 17.7 | 32.0 | 27.1 | 17.5 | 13.4 | 11.6 | 11.6 | |
| Current liabilities | 2.0 | 20.0 | 2.4 | 2.3 | 1.8 | 1.8 | 1.6 | 1.6 | |
| Short-term debt | — | — | 0.4 | 0.4 | — | — | — | — | |
| Shareholders' equity | 16.2 | -15.0 | 1.0 | -1.8 | -4.6 | 10.0 | 8.1 | 8.1 |
USD millions · SEC XBRL
Scinai Immunotherapeutics Ltd. — questions
- How much cash does Scinai Immunotherapeutics Ltd. have?
- $1.8M in cash and cash equivalents as of 2025-12-31.
- What are Scinai Immunotherapeutics Ltd.'s total assets?
- $11.6M as of 2025-12-31.
- What is Scinai Immunotherapeutics Ltd.'s shareholders' equity?
- $8.1M as of 2025-12-31.
Every figure on this page comes from Scinai Immunotherapeutics Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.